Medicare Enhancements for Needed Drugs Act of 2005
Latest action · Feb 1, 2005 Read twice and referred to the Committee on Finance.
Progress
Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.
- IntroducedFeb 1, 2005
- Passed SenateNot reached
- Passed HouseNot reached
- To the PresidentNot reached
- Became lawNot reached
Summary
Medicare Enhancements for Needed Drugs Act of 2005 - Directs the Comptroller General to review and report to Congress on the retail cost of prescription drugs in the United States during 2000 and 2003, and through April 1, 2006, with an emphasis on the prescription drugs most utilized for individuals age 65 or older.
Requires the Comptroller General to conduct an ongoing study that compares the average retail cost in the United States for each of the 20 most utilized prescription drugs for individuals age 65 or older with: (1) the average prices at which private health plans, the Department of Defense under the Defense Health Program, and the Department of Veterans Affairs acquire each such drug; and (2) the average negotiated price for each such drug that eligible beneficiaries have access to under a Medicare prescription drug plan providing only basic prescription drug coverage.
Amends title XVIII (Medicare) of the Social Security Act (SSA) to include in the comparative plan information for beneficiaries under new Medicare part D (Voluntary Prescription Drug Benefit Program) a comparison of average aggregate prescription drug plan beneficiary costs and savings with such costs for a beneficiary with no prescription drug plan.
Repeals the prohibition against interference by the Secretary with the negotiations between drug manufacturers and pharmacies and prescription drug plan sponsors, as well as the requirement of a particular formulary to institute a price structure for the reimbursement of Medicare part D covered drugs. Authorizes the Secretary instead, like other Federal entities that purchase prescription drugs in bulk, to negotiate contracts with manufacturers of covered part D drugs.
Cosponsors 8
Members who signed on, in the order they did. Signatures ran from Feb 1, 2005 to Mar 8, 2006; 4 are original cosponsors, there from the day it was introduced.
| Seat | Cosponsor | Signed on | |
|---|---|---|---|
| D-CA | Dianne Feinstein | Original | Feb 1, 2005 |
| R-AZ | John McCain | Original | Feb 1, 2005 |
| D-OR | Ron Wyden | Original | Feb 1, 2005 |
| D-WI | Russell D. Feingold | Original | Feb 1, 2005 |
| D-CO | Ken Salazar | Feb 8, 2005 | |
| D-FL | Bill Nelson | Feb 10, 2005 | |
| D-MA | Edward M. Kennedy | Feb 17, 2005 | |
| R-RI | Lincoln Chafee | Mar 8, 2006 |
Committees 1
Where it was sent and what each committee and subcommittee did with it, in order.
| Chamber | Committee | What it did |
|---|---|---|
| Senate | Finance Committee | Referred Feb 1, 2005 |
Actions 3
Everything that happened, newest first.
- Feb 1, 2005Introduced in Senate
- Feb 1, 2005Sponsor introductory remarks on measure. (CR S745-746)
- Feb 1, 2005Read twice and referred to the Committee on Finance.
In the Congressional Record 7
Days the Record’s own index lists this bill, newest first, with the pages and the members it names. Pages starting H are the House, S the Senate, E Extensions of Remarks.
| Where | In the Record | Members | Date |
|---|---|---|---|
| Senate | Debate and remarks S358 | Ron Wyden D-OR | Jan 31, 2006 |
| Senate | Debate and remarks S1597 | Ron Wyden D-OR | Feb 17, 2005 |
| Senate | Debate and remarks S1321 | Ron Wyden D-OR | Feb 14, 2005 |
| Senate | Debate and remarks S1252, S1253 | Bill Nelson D-FL, Ron Wyden D-OR | Feb 10, 2005 |
| Senate | Debate and remarks S1152 | Ron Wyden D-OR | Feb 9, 2005 |
Research
What has been written about this bill: committee reports, cost estimates, the sponsor’s authority statement, printed hearings and the Congressional Research Service’s work.
Printed hearings 1
Hearings whose printed record names this bill, newest first: hearings on it, and wider hearings where it came up.
| Number | Hearing | Committee | Held |
|---|---|---|---|
| S. Hrg. 109-114 | CONCURRENT RESOLUTION ON THE BUDGET FOR FISCAL YEAR 2006532 pages | Budget Committee | Feb 1, 2005–Mar 1, 2005 |
Titles 2
Every title it has carried, official and short, at each stage.
- Official Title as Introduced
- A bill to reduce the costs of prescription drugs for medicare beneficiaries, and for other purposes.
- Short Titles as Introduced
- Medicare Enhancements for Needed Drugs Act of 2005
Subjects
Assigned by the Library of Congress. Policy area: Health.
- Armed Forces and National Security
- Commerce
- Congress
- Congressional investigations
- Congressional reporting requirements
- Defense procurement
- Drug industry
- Drugs
- Government Operations and Politics
- Government procurement
- Health
- Health insurance
- Medicare
- Medigap
- Military medicine
- Prescription pricing
- Social Welfare
- Veterans' medical care
Text 1
Each version as it was printed, newest first.
- Feb 1, 2005Introduced in Senate
Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.